Skip to main content
Premium Trial:

Request an Annual Quote

Together for a Vaccine

GlaxoSmithKline and Sanofi are working together on a vaccine for SARS-CoV-2, the Guardian reports.

In particular, the firms are building on the approach Sanofi uses to develop its influenza vaccine, it says. According to the Guardian, Sanofi has synthesized DNA encoding the spike protein of the coronavirus that can then be introduced into bacteria to generate copies of the antigen. At the same time, the firms are using an adjuvant developed by GSK to generate a strong immune reaction.

The Guardian reports that the firms together represent much of the world's vaccine manufacturing capacity and should be able to make vaccines at the scale needed for SARS-CoV-2, should the vaccine prove effective. "By combining our science and our technologies, we believe we can help accelerate the global effort to develop a vaccine to protect as many people as possible from COVID-19," Emma Walmsley, the chief executive of GSK, says in a statement.

The firms hope to begin phase I clinical trials later this year to have a vaccine in hand by the second half of 2021, the Guardian adds.

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.